Healthcare | March 25, 2025
Our TB elimination strategy is based on ‘whole of the society’ and ‘whole of the government’ approach: JP Nadda
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
Experts urge early detection & better access to care
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
There are 38.4 million people with diabetes in the United States
Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
The launch follows the approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K.
Standalone profit from operations for Q4-2024 were Rs. 108 crore
Offers affordable, high-quality solutions for diabetes care
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients with heart failure
Subscribe To Our Newsletter & Stay Updated
